CorMedix (CRMD) Revenue (2013 - 2026)

CorMedix has disclosed Revenue across 13 years of filings, most recently posting $101.9 million for Q2 2026.

• In Q2 2026, Revenue rose 156.52% year-over-year to $101.9 million; the TTM figure through Jun 2026 stood at $374.6 million (up 208.32% YoY), while the FY2025 annual figure was $311.7 million, up 617.03% from the prior year.
• Revenue came in at $101.9 million for Q2 2026 at CorMedix, down from $128.6 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $128.6 million in Q4 2025 to a low of $6817.0 in Q3 2022.
• Average Revenue over 4 years is $38.1 million, with a median of $21.3 million recorded in 2024.
• Year-over-year, Revenue slumped 91.35% in 2022 and soared 4829.3% in 2025.
• Over 4 years, Revenue stood at $29702.0 in 2022, then surged by 104976.31% to $31.2 million in 2024, then soared by 312.1% to $128.6 million in 2025, then dropped by 20.75% to $101.9 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $101.9 million in Q2 2026, $128.6 million in Q4 2025, and $104.3 million in Q3 2025.